Delivery Order SPE2DR25D3103-SPE2DR26F9F60

The Defense Logistics Agency awarded a delivery order valued at $4,577.70 to AmerisourceBergen Drug Corp for Rytary ER (extended-release carbidopa/levodopa) 36.25 mg-145 mg capsules in a quantity of 100 units. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of November 17, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child contract executed under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026 that enables the supply of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Rytary is a neurological treatment medication used for Parkinson's disease management, consistent with the company's extensive portfolio of specialty medications, brand-name and generic drugs, and medical supplies delivered through competitively awarded contracts with the Defense Logistics Agency. The company's demonstrated capability to fulfill federal medical supply requirements through open competition, combined with its established position as a pharmaceutical prime vendor for the military healthcare system, positions it as a primary source for critical medication deliveries supporting federal beneficiaries.